We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+19.58%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$521M
AUM Growth
+$123M
(+31%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
14.2%
Top 10 Holdings %
Top 10 Hldgs %
42.06%
Holding
160
New
57
Increased
37
Reduced
27
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$11.3M |
| 2 |
Amazon
AMZN
|
+$11.3M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$10.5M |
| 4 |
Medifast
MED
|
+$10.1M |
| 5 |
CTLP
Cantaloupe
CTLP
|
+$8.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$13.6M |
| 2 |
CVS Health
CVS
|
+$12.8M |
| 3 |
Sunrun
RUN
|
+$11M |
| 4 |
Adobe
ADBE
|
+$10.1M |
| 5 |
ServiceNow
NOW
|
+$8.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.67% |
| 2 | Industrials | 16.23% |
| 3 | Healthcare | 15.24% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Consumer Staples | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alphabet (Google) Class C
GOOG
$4.07T
| $1.47M | 0.28% |
+25,000
| New | +$1.4M |
|
|
FIT
52
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.19M | 0.23% |
+202,000
| New | +$1.23M |
|
53
Global Water Resources
GWRS
$215M
| $1.15M | 0.22% |
117,000
| – | – |
|
54
Walt Disney
DIS
$172B
| $999K | 0.19% |
+9,000
| New | +$1.01M |
|
|
55
ServiceNow
NOW
$114B
| $986K | 0.19% |
20,000
-195,000
| -91% | -$8.57M |
|
56
Electronic Arts
EA
$52.4B
| $915K | 0.18% |
+9,000
| New | +$853K |
|
57
iShares Biotechnology ETF
IBB
$9.55B
| $894K | 0.17% |
8,000
-4,000
| -33% | -$439K |
|
58
Stryker
SYK
$133B
| $889K | 0.17% |
4,500
| – | – |
|
59
Novartis
NVS
$304B
| $865K | 0.17% |
10,044
+2,232
| +29% | +$179K |
|
60
Boston Scientific
BSX
$68.5B
| $864K | 0.17% |
22,500
+2,500
| +13% | +$95.5K |
|
61
Abbott
ABT
$187B
| $840K | 0.16% |
10,500
+5,500
| +110% | +$409K |
|
62
PUT
Meta Platforms (Facebook)
META
$1.51T
| $833K | 0.16% |
5,000
| – | – |
|
|
VTNR
63
DELISTED
Vertex Energy, Inc
VTNR
| $805K | 0.15% |
500,306
+8,000
| +2% | +$10.7K |
|
|
CWEN.A
64
DELISTED
Clearway Energy Class A
CWEN.A
| $800K | 0.15% |
55,000
-368,048
| -87% | -$5.38M |
|
65
Lyft
LYFT
$5.87B
| $784K | 0.15% |
+10,000
| New | +$783K |
|
66
HCA Healthcare
HCA
$92.8B
| $782K | 0.15% |
6,000
+2,000
| +50% | +$269K |
|
67
Medtronic
MDT
$111B
| $729K | 0.14% |
8,000
-2,500
| -24% | -$224K |
|
68
GDS Holdings
GDS
$6.14B
| $714K | 0.14% |
20,000
-5,000
| -20% | -$151K |
|
69
Coherus Oncology
CHRS
$222M
| $682K | 0.13% |
50,000
+35,000
| +233% | +$467K |
|
70
Resideo Technologies
REZI
$5.55B
| $675K | 0.13% |
35,000
+20,000
| +133% | +$443K |
|
71
Eli Lilly
LLY
$1.09T
| $649K | 0.12% |
+5,000
| New | +$608K |
|
|
VMW
72
DELISTED
VMware, Inc
VMW
| $632K | 0.12% |
+3,500
| New | +$570K |
|
|
QTNT
73
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $631K | 0.12% |
1,750
-1,000
| -36% | -$352K |
|
|
PFPT
74
DELISTED
Proofpoint, Inc.
PFPT
| $607K | 0.12% |
+5,000
| New | +$548K |
|
75
Broadcom
AVGO
$1.81T
| $601K | 0.12% |
+20,000
| New | +$542K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Ardsley Advisory Partners held 160 positions worth $521M, up 31% from $398M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners deployed $74M of net new capital in Q1 2019, opening 57 new positions and adding to 37 existing holdings. Its largest new stake was Medifast: 80,000 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Sunrun, an estimated $11M trimmed.
- Ardsley Advisory Partners's largest Q1 2019 buy was Medifast: 80,000 shares worth $10.2M.
- Ardsley Advisory Partners added most to Celgene Corp in Q1 2019, an estimated $11.3M increase.
- Ardsley Advisory Partners's biggest Q1 2019 reduction was Sunrun, cutting an estimated $11M.
- Ardsley Advisory Partners fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $13.6M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $521M portfolio in Q1 2019.
- Ardsley Advisory Partners opened 57 new positions and closed 29 in Q1 2019.
- Ardsley Advisory Partners's portfolio value rose 31% quarter-over-quarter to $521M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.